Conjugated Pneumococcal Vaccine Triggers a Better Immune Response than Polysaccharide Pneumococcal Vaccine in Patients with Chronic Lymphocytic Leukemia - A Randomized Study by the Swedish CLL group

Tobias Svensson,Magdalena Kättström,Ylva Hammarlund,Daniel Roth,Per-Ola Andersson,Magnus Svensson,Ingmar Nilsson,Lars Rombo,Honar Cherif,Eva Kimby

Conjugated Pneumococcal Vaccine Triggers a Better Immune Response than Polysaccharide Pneumococcal Vaccine in Patients with Chronic Lymphocytic Leukemia - A Randomized Study by the Swedish CLL group

2017

Tobias Svensson
Magdalena Kättström
Ylva Hammarlund
Daniel Roth
Per-Ola Andersson
Magnus Svensson
Ingmar Nilsson
Lars Rombo
Honar Cherif
Eva Kimby

Aim: To determine if patients with untreated chronic lymphocytic leukemia (CLL) benefit from vaccination with a 13-valent conjugated pneumococcal vaccine (PCV13), Prevenar13®, compared with a 23-va ...

Keywords:

Untreated Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia
Pneumococcal vaccine
Randomized controlled trial
Vaccination
Immune system
Immunology
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations